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1. Introduction 
Renal cell carcinoma (RCC) is the most frequent malignant neoplasm of the kidneys, 
accounting for 85% of all renal cancers, and 2% of all adult malignancies. Forty-five percent 
of these tumors have been diagnosed as locally advanced or metastatic disease (Stage IV, 
according to the American Joint Committee on Cancer staging system), and the five-year 
survival rate varies between 0 to 8% according to the United States National Cancer Data 
Base (American Cancer Society, 2011). Bones metastases from renal cell carcinoma occur in 
up to 50% of patients (Swanson et al., 1981), and from this group approximately one half is 
located in the spine. RCC is the fourth most common metastatic tumor of the spine and the 
most common cancer to present as a neurologic deficit secondary to an undetected primary 
malignancy. According to Les et al, the prognosis is generally worse when metastases occur 
in the axial skeleton rather than in the extremities. In general, the average survival of all 
patients diagnosed with metastatic RCC is about four months and only 10% of these survive 
for one year (Thyavihally et al., 2005).  
The RCC has a well know angiotropism associated to the anatomical and hemodynamic 
characteristics of the blood supply of the spine, and to the persistence of hematopoietic 
tissue inside the vertebral body, making this region the most susceptible localization for the 
metastases in the spine.  
Vertebral lesions determine a severe compromise of the quality of life, with pain that can 
become intractable and a high risk of vertebral fracture and/or paralysis. The substitution of 
the healthy bone with the metastatic tissue cause a weakening of the vertebra, and 
sometimes an acute fracture with spinal canal invasion, that can be the most dramatic result 
from the clinical point of view.  
Kidneys cancer cells are not usually susceptible to chemotherapy agents and traditional 
radiation therapy. Only a small number of patients have been shown good responses to 
these drugs vinblastine, floxuridine, 5-fluorouracil (5-FU), capecitabine, and gemcitabine, 
and therefore it should be reserved for cases in which target drugs and/or immunotherapy 
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are not effective. Radiation therapy can be used for patients that the general health is too 
poor to have surgery, however it is not routinely recommended because there is no evidence 
that it can improve survival.  
The management of bone metastasis from RCC is often a difficult task. The progressive 
improvement in the survival rate of the patients due to new forms of treatment, and the 
radiation therapy, and chemotherapy resistance associated to this tumor, imposes a great 
challenge to its proper treatment. The role of the spine surgeon in these cases, is to choose 
the best treatment considering not only the factors associated with the primary tumor, but 
specially the individual characteristics of every patient.  
New therapies, known as “target therapies”, directed to specific molecular targets 
implicated in angiogenesis and tumor proliferation have presented encouraging results. 
Even though these results coupled with a fuller understanding of molecular pathways in 
RCC have paved the way for new targets in the treatment of kidney cancer. These drugs are 
often used as the first line of treatment against advanced kidney cancers. While they may 
shrink or slow the growth of the cancer, it does not seem that any of these drugs can actually 
cure RCC (American Cancer Society, 2011). Immunotherapy associated to surgery should 
also be considered the first treatment of choice in selected cases or in cases of failure of 
previous treatment with target therapies. In the authors’ experience, this treatment has been 
the one to show the best results so far. The surgical treatment of the spine metastasis varies 
from local decompression to en bloc resection of the lesion. Although the en bloc resection 
does not have the objective to cure the patient from the disease, it should be considered to 
minimize the risk of local disease progression (Les et al., 2001). However, many patients 
treated with en bloc resection can still develop local recurrence.  
2. Metastatic pathways to the spine 
The tumor dissemination to the bone can come from three pathways: direct extension, the 
lymphatic vessels and, the most frequent, the hematogenous pathway. The most frequent 
site in the vertebrae is the vertebral body, because of its abundant vascularization and the 
presence of bone marrow inside.  
In 1928, Ewing suggested that the metastatic diffusion was influenced only by mechanical 
factors. The abundant tortuous vessels inside the vertebral body contribute to the metastatic 
embolus deposit locally and the localization of the blood vessels near the vertebral end plate 
can explain the normal localization of the metastases in the spine. Batson showed in 1940 the 
role of the paravertebral venous plexus in the metastatic dissemination of pelvic and 
abdominal tumors to the spine. This valveless plexus allows a retrograde blood flow from 
the inferior vena cava to the paravertebral venous plexus any time that the intra-abdominal 
or intra-thoracic pressure rises, even if temporally. This retrograde flow can deliver 
metastatic embolus direct to the spine, escaping from the natural filters of the organism, as 
the liver and lungs. 
Renal cell carcinoma presents a peculiar venotropism, which is the capacity of its cells to 
reach the venous circulation. The diffusion can occur through an anterograde flow in the 
renal vein to the inferior cave vein reaching the right atrium, or through a retrograde 
diffusion. Moreover, the anatomical connections between the renal venous circulation and 
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the paravertebral venous plexus through the azygos and hemiazygous systems can also 
favor a metastatic implantation at the spine. 
The associations of the well-known angiotropism of the renal cell tumors, the anatomical 
and the hemodynamic characteristics of the spinal circulation, and the persistence of the 
hematopoietic tissue inside the vertebral spongeous bone matter are the responsible for the 
high frequency of metastasis of RCC.  
3. Diagnosis  
3.1 Clinical diagnosis 
The early diagnosis of metastatic spinal disease is important because functional outcomes 
depend on neurologic condition at the time of presentation. The presentation of spinal 
metastases can vary widely from back pain to different degrees of neurologic deficit 
including complete paralysis at the lesion level. Pathologic fracture and a complete spinal 
cord lesion are the worse conditions associated to the spinal disease and, in most of the 
cases, can and should be avoided. Clinically, the symptoms associated to RCC spinal 
metastases do not differ from most of the other metastatic primary tumors. The past history 
of renal cell carcinoma is usually the most important clue to localize the primary site. Often, 
spinal metastases can occur in patients submitted in the past to nephrectomy to treat RCC, 
and that have been considered as “no evidence of disease” for several years.  
Back pain is the most common symptom caused by spinal metastases, and often precedes 
the neurologic symptoms by weeks, sometimes even months. In some cases, back pain can 
be the first symptom related to the original cancer disease, and the primary site diagnosis is 
reached through a biopsy of the spinal lesion. There are mainly three different sources of 
back pain: mechanical, radicular and local pain. The mechanical pain is caused by the spinal 
instability secondary to the structural abnormality of the spine, and is also known as axial 
back pain (Gokaslan and York, 1998). The instability can be diagnosed because of its clinical 
symptoms or with obvious alterations such as pathologic fractures. This pain is movement-
related and exacerbate by sitting or standing which increases the axial load on the spine. 
Patients presenting with pathological fractures of the spine may also present pain in 
recumbence and often give a history of sleeping upright in a chair for several weeks. The 
presumed mechanism is extension of the unstable kyphosis. At the beginning, mechanical 
pain maybe relieved with narcotics or an external orthosis, however it does not respond to 
steroids. The source of local pain can also be increased by the muscle, tendon, ligament 
and/or joint capsule strain that secondarily occurs from the vertebral body damage. 
Radicular pain may occur when spinal metastases compress or irritate an exiting nerve root, 
yielding pain in the dermatomal distribution of the involved nerve root. This type of pain is 
often described as “sharp,” “shooting,” or “stabbing” (Perrin et al., 1982). The periosteal 
stretching and/or a local inflammatory process stimulate the pain fibers within the 
periosteum causing local pain. It is predominantly nocturnal or early morning pain and 
generally improves with activity during the day, and it is usually described as a persistent 
“gnawing” or “aching” pain originated from the affected spinal segment. Inflammatory pain 
usually responds to administration of low dose steroids. 
The second most common presenting complaint is motor dysfunction. Myelopathic 
abnormalities begins with hyperreflexia, clonus, Babisnki reflex and can progress to 
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weakness, proprioceptive sensory loss, and loss of pain and temperature below the level of 
spinal cord compression. Autonomic dysfunction can occur secondarily to spinal cord 
compression or cauda equina compression. Bladder dysfunction is the most common 
autonomic finding and often correlates with the degree of motor dysfunction (Schiff 2004). 
The proper identification of neurologic deficit is of paramount importance, considering the 
motor function at the time of diagnosis correlates with the prognosis (Arguello et al., 1990). 
Unfortunately, the presence of back pain is extremely common in the general population, 
and it is likely that delay diagnoses of vertebral metastases occur in the presence of only 
back or neck pain. For these reasons, in every patient with a past history of RCC, the 
hypothesis of vertebral metastasis must be considered until proven otherwise. 
Generally, the motor dysfunction is associated with sensory dysfunctions, such as 
anesthesia, hyperesthesia, hypoesthesia and/or paraesthesia. Complains of sensory 
abnormalities can occur in the dermatomal distribution of the radicular pain or weakness, 
while the patients with myelopathy may elicit a sensory level across the chest or abdomen. 
The clinical evaluation of spinal patients should include general performance status, a pain 
assessment and a quantitative neurologic score. The most common method of pain assessment 
is the visual analog scale. The performance status reflects ambulation, medical comorbidities 
and extent of the disease. A patient may have normal motor strength, but be unable to walk 
from loss of proprioception, fracture of lower limbs or from a variety of other reasons. 
The neurologic status is assessed using the modified Frankel grading system (McGuire et al., 
1998) and/or the American Spinal Injury Association (ASIA) score (Table 1). Both systems 
assess the motor function with a score of “E” being normal and “A” being a complete 
paralysis. 
 
Grade Description A Complete: No motor or sensory function is preserved in the sacral segments 
S4-S5. B Incomplete: Sensory but not motor function is preserved below the 
neurological level and extends through the sacral segments S4-S5. C Incomplete: Motor function is preserved below the neurological level, and the 
majority of the key muscles below the neurological level have a muscle grade 
less than 3. D Incomplete: Motor function is preserved below the neurological level, and the 
majority of the key muscles below the neurological level have a muscle grade 
greater than 3. E Normal: Motor and sensory function is normal. 
Table 1. ASIA impairment scale. 
The modified Frankel score system divides the clinical-neurologic status in seven stages: 
- A: Complete loss of the motor and sensitive functions. 
- B: Presence of sensory but absence of voluntary motor functions. 
- C: Motor deficit that allows the deambulation, but only with antibrachial support and 
lower limbs bracing. 
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- D1: High degree of motor deficit that allows deambulation using only an antibrachial 
support, and/or bladder or bowel paralysis.  
- D2: Moderate degree of motor deficit that allows the deambulation without support or 
bracing, and/or bladder or bowel neurologic dysfunction. 
- D3: Mild motor deficit with a normal bladder and bowel functions. 
- E: Complete motor and sensitive function (osteotendinous reflexes can be abnormal)  
3.2 Diagnostic imaging 
Plain radiography (with or without myologram), myelography, computed tomography (CT) 
(with or without myelogram), magnetic resonace imaging (MRI), and positron emission 
tomography (PET) all play important roles in the imaging assessment of spinal cancer and 
metastatic lesions from RCC. 
3.2.1 Plain films 
Plain radiographs are readily available, easy to perform, relatively low cost, and provides a 
detailed assessment of osseous structures. Lytic or sclerotic areas of bone, pathologic 
compression fractures, deformity, and paraspinal masses can be seen, however, according to 
Gabriel et al., up to 50% of the bone must be eroded before there is a noticeable change on 
plain radiographs.  
3.2.2 Computed tomography (CT) 
CT provides a detailed assessment of osseous structures and the extent of tumor 
involvement within the bone. It is indispensible for pre-operative staging according to the 
Weinstein-Boriani-Biagini and surgical planning (Boriani et al., 1997). When associated to 
myelography, it demonstrates any suspected compression of the neural elements caused by 
tumor extension to the canal or osseous fragments from a pathologic fracture. 
The CT is very important also to evaluate the risk of pathologic fracture based on the 
tumor’s extension in the vertebrae. 
3.2.3 Nuclear scintigraphy 
Nuclear scintigraphy or bone scan demonstrates areas of active bone metabolism. A major 
advantage of bone scans is its cost-effective ability to scan the entire axial and appendicular 
skeleton at the same time and its capacity of revealing lesions at an earlier stage when 
compared to plain films. Its disadvantage is the low specificity, as increased metabolic 
activity in the presence of inflammation or infection. The image correlation with CT and 
MRI is necessary due to its low imaging resolution. The PET scanning with 18F-
fluorodeoxygucose is more sensitive and specific for whole body metastatic evaluations, but 
as with bone scans, it also necessitates concomitant use of CT or MRI. Koga et al, assessed 
the diagnostic value of bone scan in 205 patients with confirmed renal cell carcinoma, and 
concluded that bone scan may be omitted in patients with stages T1-3aN0M0 tumors and no 
bone pain because of the low proportion of missed cases with bone metastasis (Koga et  
al., 2001). 
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3.2.4 Magnetic Resonance Imaging (MRI) 
MRI is currently the gold standard imaging technique for assessing the spinal metastasis. It 
combines excellent spatial and contrast resolution. MRI is also more sensitive than CT, and 
bone scans, and does not exposes patients to ionizing radiation. It provides superior 
resolution of soft-tissue structures such as paraspinal muscles, intervertebral disc, spinal 
cord and nerve roots. Standard MRI protocols include T1-weighted images (T1 WIs) without 
and with intravenous contrast, T2-weighted images (T2WIs) in axial, coronal and sagittal 
reconstructions. Fat suppression techniques are useful in evaluating osseous lesions that 
enhance with contrast. Disadvantages include relatively long acquisition times, 
insurmountable safety contra-indications in some patients, and lower sensitivity to osseous 
structural abnormalities. 
3.2.5 Angiography 
Metastasis from hypervascular tumors as RCC may have diagnostic and therapeutic benefits 
from angiography. Pre operative angiography can provides the knowledge about the 
tumors vascular supply and allows preoperative embolization, decreasing the blood loss 
during the intralesional excision. 
3.3 Anatomopathologic diagnosis 
Percutaneous biopsy to confirm the diagnosis is paramount. Although imaging modalities 
can provide a great definition of the anatomical aspects of the lesions the correct diagnosis is 
mandatory prior to the treatment planning. Patients with well-known primary cancer can 
present with a spinal lesion from another hidden metastatic tumor or a primary bone tumor 
associated. CT guided percutaneous trocar biopsies provide relatively easy access to most 
lesions with success rates approaching 90%. Traspedicular biopsy is the most adequate 
technique because of the smaller contamination of the adjacent tissues, facilitating its 
removal during the resection. 
4. Management of spinal metastasis 
When dealing with spinal metastasis factors need to be taken into consideration by the 
oncologist, spine surgeon, anesthesiologist and the entire multidisciplinary group involved 
in the caring of these patients. Considering that metastatic disease to the spine a systemic 
disease, at first, the curative excision of the entire secondary lesion does not seems 
necessary, particularly in the spine because of its anatomical characteristics and morbidity. 
The palliative treatment frequently applied has the primary objective to decrease the pain, 
stabilize the spine and, whenever is necessary, decompress the adjacent neural structures. 
The intralesional excision of the tumor (inadequate oncological margins) can be complete or 
incomplete, allowing a circumferential decompression of the spinal cord and a better local 
control of the disease. 
RCC is well known as radiation therapy and chemotherapy resistant, and immunotherapies 
with cytokines based on interferon alpha and interleukin-2 (IL2) have shown poor results with 
significant toxicities. New therapies directed to molecular targets implicated in angiogenesis 
and tumor proliferation are being developed. Sunitinib is considered one of the new reference 
first-line treatment for RCC metastasis, however despite all the progress in recent years, 
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complete responses are still very rare, and many important issues regarding the use of these 
agents in the management of metastatic renal cell cancer still need to be properly addressed.  
Surgical treatment has been the only recognized therapy to improve the quality of life in the 
patients with RCC metastatic disease in the spine. In most of the cases the surgery does not 
improve the survival prognosis of these patients but it can dramatically improve the their 
life quality. Moreover, in a small group of patients with solitary spinal RCC metastases the 
en bloc resection has shown to substantially improve the overall survival time. In their 
retrospective work, Thyavihally et al. demonstrated the complete resection of either 
synchronous or metachronous solitary metastases from RCC is justified and can contribute 
to a long-term survival in a selective group of patients. They also concluded that patients 
with long interval between diagnosis and development of metastasis and early stage of the 
primary tumor have a better prognosis after en bloc resection of the metastases. 
The treatment goals of spinal metastasis is different than the primary bone tumors, the first 
one aims the patient’s quality of life while the main target of primary bone tumor is to 
preserve life. The best treatment” should include local control of the disease and restoration 
of the spinal function.  
4.1 Treatment planning 
Surgical indications for spinal metastasis in general, have been subject of controversy 
because the ideal moment, patient and surgical technique are still trying to be defined in the 
literature. Many strategies have been proposed trying to appropriately direct the best 
surgical treatment. In 1987 Tokuhashi et al. published a point-addition-type scoring system 
for the preoperative prediction of the survival period to select treatment options. This score 
system was later on revised and magnified its the application to the group with conservative 
treatment. The general condition (Karnofsky performance status), the number of extraspinal 
bone metastases, the number of metastases in the vertebral column, the presence of 
metastases to major internal organs (lungs, liver, kidneys, and brain), the primary site of 
cancer, and the severity of spinal cord palsy were the items evaluated. Each parameter 
ranged from 0 to 5 points, and the total score was 15 points. RCC was considered as 
moderate prognosis receiving three points in the item “primary site of cancer”. Tomita et al, 
also have described a scoring system based on the primary tumor, the presence of 
metastases to the vital organs and number of bone metastases. These systems have been 
used among the spine surgeons with reasonable results, unfortunately the scores systems 
are too simple, based in numbers that allocates extremely different types of patient in the 
same group, and also they do not consider the clinical status and other physicians opinions 
involved in the patient’s care before deciding the best treatment option.  
In 2008, the authors published their own treatment algorithm to guide the decision planning 
when dealing with spine metastasis, based on a retrospective study of 43 patients 
(Cappuccio et al., 2008). According to Cappucio et al., multidisciplinary treatment could be 
beneficial, and a failure to do so, is very like to end in a suboptimum prognosis and could 
even lead to sever impairment. The treatment planning, including the surgical planning 
should involve not only the spine surgeon, but also the nonsurgical physicians (anesthetist, 
oncologist, radiotherapist), and it should be chosen on each individual patient. Gasbarrini et 
al., conducted a semi-prospective clinical study in 2010 with 202 patients to evaluate the 
efficacy of this algorithm which furthermore evolved to a flow chart (Figure 1). 
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Fig. 1. Flow chart for the treatment of spinal metastasis. 
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According to this flow-chart, all spinal tumors must be staged, and the first question when 
planning the treatment is to discuss with the oncologist about the life expectancy of the 
patient and to reach a consensus with the anesthesiologist if the patient is operable or not 
(based on the ASA score). Other important items to consider is the neurological status and 
its capacity to deteriorate or to improve, the presence of pathologic fracture, the sensitivity 
of the primary tumor to non surgical therapies, and the number of spinal, bone or visceral 
metastasis. Following the flow chart the best therapeutic option can be achieved, ranging 
from only pain therapy to surgical procedures as en bloc resections. 
Considering the RCC metastases, the surgical treatment is the only method that can improve 
the patient’s quality of life, and in some well selected cases of single spinal metastases, a 
cure of these patients have been well documented after en bloc resections (Li et al., 2009). 
Patients with disseminated RCC metastasis, or clinically incapable to be submitted to 
surgical procedures, pain therapy is indicated. 
4.2 Surgical planning 
In order to apply the surgical indication determined by the oncological staging and the 
Gasbarrini’s flow chart, it is necessary a complete work-up to evaluate the vertebral tumor 
that will be treated. The histological diagnosis, preferably obtained by CT-guided biopsy, is 
fundamental. Magnetic resonance imaging, CT-scan and in some selected cases, 
angiography, are the imaging techniques indicated to describe the tumor’s extension on the 
transversal and longitudinal planes. The first attempt to determine a surgical staging system 
to guide the spine surgeons was made by Weistein in 1994. Boriani and Biagini modified 
this staging system in 1997 (Figure 2).  
  
Fig. 2. WBB surgical staging system 
4.2.1 Weinstein–Boriani–Biagini (WBB) surgical staging 
The WBB surgical staging system is specific for spine tumors and was created to guide the 
planning of the surgical resection to achieve the appropriate histologic margins. It was first 
A. Extraosseous Soft 
Tissue 
B. Intraosseous 
(Superficial) 
C. Intraosseous (Deep) 
D. Extraosseous 
(Extradural) 
E. Extraosseous 
(Intradural) 
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described to treat primary spinal tumors, but its application was later on extended to the 
treatment of spinal metastasis as well. Pre-operative CT-scan and MRI are required to 
provide detail of the lesion and the normal tissues surrounding it.  
The WBB divides the axial presentation of the vertebrae involved with the tumor into 12 
zones similar to a clock face. Zone 1 is located at the left half of the spinous process followed 
by the others in a counter clockwise sense. Zones 4 and 9 are particularly important to know 
because they define respectively the left and right pedicles. Vertebrectomy with adequate 
surgical margins depends upon one of these zones to be free of tumor. The vertebra is 
further divided into 5 radial zones that define the depth of tumor invasion. These zones are 
also known as layers, starting from layer A that corresponds to the outside surrounding 
tissue of the vertebra to layer E that indicates intradural involvement of the tumor. In the 
cervical spine there is also layer F, which corresponds to the vertebral artery involvement. It 
is also important to describe the longitudinal extension of the tumor.  
4.2.2 Pre-operative Selective Arterial Embolization (SAE)  
Vertebral metastases of renal origin are highly vascular and often cause life-threatening 
intraoperative bleeding. This bleeding may influence the surgeon’s ability to have an 
adequate view of the surgical field, and thus to achieve a complete resection. Preoperative 
embolization facilitates resection by decreasing intraoperative blood loss, improving 
visualization of the tumor during surgery, and decreasing tumor size. 
Embolization can also be used as a palliative treatment in patients who are poor operative 
candidates or have recurrent, multiple, or unresectable tumors. It can also be used to treat 
painful metastatic disease or for patients with neurologic compromise from metastatic 
lesions by reducing the tumor size, tumor growth, and spinal canal compromise. 
In cases of vascular metastatic spinal lesions, as in the RCC metastasis, a preoperative 
angiography should be performed to demonstrate the hypervascularity of the lesion, to 
identify the main arterial feeders, and, ultimately, to determine whether the lesion would 
benefit from the embolization. Angiography of a spinal RCC metastatic lesion typically 
demonstrates a hyper-dynamic pathologic circulation within the vertebral tumor, enlarged 
feeding intercostals or lumbar arteries, angiographic blush caused by venous congestion 
within the tumor nidus, and, possibly, a rapid arteriovenous transit with early filling of 
draining venous channels (Figure 3A). The enlarged venous pool may contribute to a 
tumor’s mass effect; therefore, embolization may decrease spinal cord compression. Before 
embolization procedures, it is important to identify the segmental vessels that supply the 
spinal cord and the radiculomedullary branch of the anterior spinal artery and to determine 
whether an anterior spinal artery shares the same pedicle as the feeding artery of the tumor. 
The presence of an anterior spinal artery, also known as artery of Adamkiewicz (Figure 3B), 
at the same pedicle as the feeding artery at the tumor is considered by many authors a 
contraindication for embolization due to the risk of spinal cord ischemia, however some 
authors have demonstrated in animals models that in the presence of more than one artery 
of Adamkiewicz artery, the embolization of the tumor feeder would not cause damage to 
the spinal cord. Tomita et al., published in 2009 their techniques on total en bloc 
spondylectomy and showed that preoperative embolization of bilateral segmental arteries at 
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three levels (at the level of the tumor, and one segment above and another one bellow) 
should be tried within 48 hours before the operation.  
There are many reports of surgeries on metastatic renal cell carcinoma that were aborted 
because of “uncontrollable bleeding” or excessive blood loss in control groups that did not 
have preoperative SAE, whereas no case was aborted were complete embolization was 
done. 
  
Fig. 3. A. Tumoral “blush” during angiography showing a metastatic RCC lesion in T10;  
3B. Artery of Adamkiewicz. 
In some cases of neurologic worsening before SAE was done the immediate surgery before 
the embolization can result into severe complications. Sundaresan et al., had 54% of 
complications in patients with RCC metastasis that were rushed into surgery without 
preoperative SAE. Because of this high rate of complications, some authors advocates for a 
delaying surgery for a few hours to perform preoperative embolization.  
The choice of embolic material is based on the territory embolized, the vascular anatomy of 
the tumor, and the ability of selective delivery of an embolic agent via a catheter. The 
success of an embolization is judged by reduction in tumor vascularity and lack of tumor 
blush.  
The timing of surgery after preoperative SAE is an important technical consideration. It is 
recommended that embolization be performed as close as possible to the time of surgery. 
Minimal blood loss occurs after embolization if surgery is performed within 24 to 48 hours 
after embolization. Earlier surgeries prevent the development of collateral circulation. The 
intraoperative blood loss can be reduced from one to two thirds in RCC metastatic lesions 
(Gottfried et al., 2004). 
Complications rates are very low and have been reported to vary from 1% to 2%. Most 
complications are temporarily and are associated to a post-embolization syndrome that 
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includes malaise, nausea, emesis, low-grade fever, elevated white blood cell count, and local 
pain usually lasting three to seven days. Permanent paraplegia has been reported in the 
literature, but fortunately it is very rare. 
4.3 Surgical treatment 
In the past the patients with spinal metastasis were considered as terminal patients, 
therefore surgical treatment was reserved for patients with uncontrollable pain with 
medications, or patients with high risk of pathologic fracture. The surgical approach to the 
spine is basically anterior or posterior. Both approaches can be also combined in the same 
surgery or in separated surgical procedures. 
The rational behind the adequate surgical option should include: 
- The best decompression possible. 
- The most efficacious spinal stabilization. 
- Removal of the tumor with oncological adequacy.  
The correct surgical treatment does not involve simple laminectomy of the spine of any 
extension. The outcomes of this procedure are comparable to isolated radiation therapy and 
can result in a severe instability with a high risk of neurological deterioration.  
The surgical techniques to be considered are: 
1. Spinal decompression and stabilization. 
2. Intralesional excision (debulking) and spinal column reconstruction. 
3. En bloc resection and spinal column reconstruction. 
4.3.1 Decompression and stabilization 
This is the fastest and less aggressive surgical procedure aiming to decompress the spinal 
cord and to stabilize the spine. This procedure does not necessarily include a direct 
approach to the tumor. It is considered a palliative treatment. 
The indications for decompression and stabilization are: 
1. Presence, or elevated risk, of pathological fracture in the thoracic and/or lumbar spine. 
2. High sensitive tumors to hormonal, chemotherapy or radiotherapy, independently of 
the neurological status. 
3. Patients with extremely poor prognosis aiming only the improvement of the patient’s 
quality of life. 
4.3.2 Intralesional excision 
Intralesional excision includes a direct approach to the tumoral mass with a partial resection 
of the tumor in order to reach spinal decompression and tumor mass reduction. This 
procedure is considered more aggressive than simple decompression and stabilization, 
especially when dealing with systemic diseases, and it must include a multidisciplinary 
approach. Selective arterial embolization should be included in the treatment to decrease the 
hemorrhage, very often life threatening, and also a detailed surgical planning to achieve an 
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adequate excision and to reconstruct the spinal stability. Some times a double approach 
should be considered.  
The indications for intralesional excision are: 
1. Tumoral mass compression from radio-resistant metastasis. 
2. Pathologic fractures in radio-resistant metastasis. 
3. Necessity to reduce the tumoral mass (“debulking”) in order to apply adjuvant 
therapies. 
Surgical technique 
The surgical technique for intralesional excision depends on the location of the metastases. 
In the cervical spine the approach is always anterior, and for the thoracic and lumbar spine, 
a partial excision can be performed also using a posterior approach. 
Cervical Spine: The anterior approach to the cervical spine (from C3 to T1) is well known 
among the spine surgeons. The approach to C1 and C2 can be transoral or extra-oral. An 
extension of this approach can be done through a very aggressive trans-mandible technique.  
The vertebral arteries are a problem for the circumferential approach. The single anterior 
approach is indicated in the lower cervical spine for small metastasis (WBB: from sector 4 to 
9). Every time that a tumor is located in the posterior elements, invading at least one 
articular process, a double approach not only is safer, but also indicated for the 
reconstruction in general. 
Thoracic Spine: The metastasis in the thoracic spine can be completely excised through a 
thoracotomy using the classical anterolateral approach, technically challenging in the 
cervical-thoracic junction. Using only a posterior approach is also possible to perform a 
complete curettage of the lesion, legating one nerve root.  
Thoracoscopy can also be used for intracapsular excision (McLain 2001).  
Lumbar Spine: In the lumbar spine, the anterior approach with decompression, and 
reconstruction usually is the best option for an anterior lesion. A posterior approach at this 
level needs to scarify one or more nerve roots. The consequences of such action are 
persistent pain, loss of mobility and spinal cord ischemia.  
4.3.3 En bloc resection 
Stener in1989, and Roy-Camille in 1990, described the surgical techniques for en bloc resection 
in the thoracic and lumbar spine. Later in 1994, Tomita et al., described a similar technique for 
vertebrectomy using a posterior approach developed specially for spinal metastasis.  
The preoperative planning is paramount to choose the best technique for en bloc resection. 
Each vertebral lesion needs to be evaluated carefully and the resection should be 
“customized”. In order to plan the resection, all tumors should be surgically staged 
according to the WBB system, previously described.  
The resection can be made throughout the external surface of the pseudocapsule (marginal 
resection), or outside of it, along with a margin of healthy tissue (wide resection).  
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The well accepted indications for en bloc resections are stage three benign tumors and in 
stage one, or stage two, primary malignant tumors. The indications for spinal metastasis are 
still controversial, however it should be considered in cases of a solitary metastases of 
primary tumors with longer life expectancy, as in the RCC. 
Types of en bloc resections:  
- Sagittal resection: The criteria to obtain oncologically adequate margins include: No 
extension to the layer D in the WBB system, or limited extension with dissection plane 
between the tumor’s pseudocapsule and the dural sac. 
- Posterior resection: According to the WBB system, the indications for posterior elements 
resection with oncological margins include sectors four and nine free of tumor e no 
extension to the layer D, or limited extension with dissection plane between the tumor’s 
pseudocapsule and the dural sac. 
- Vertebrectomy: The en bloc resection of the vertebral body is oncologically appropriate 
by a posterior approach only, in cases of tumors located inside the body (no invasion of 
layer A in the WBB system). If tumor mass is expanding anteriorly in layer A or when 
the tumor is located at the cervico-thoracic, thoraco-lumbar, lumbo-sacral junction, the 
surgical procedure should include an anterior release. In these cases, the posterior 
approach ends with the blunt dissection of the lateral aspect of the vertebral body not 
involved by the tumor, if exists. Cervical spine en bloc vertebrectomy is also feasible, 
however this technique is more difficult and associated to a higher morbidity and 
mortality because of its elevated risk of vertebral artery and spinal cord injuries. 
Surgical technique  
Sagittal resection: This technique aims at achieving en bloc resection of a tumor excentrically 
growing: it consists in the piecemeal removal of the uninvolved posterior elements in order 
to circumferentially release the dura and finalize the resection by a sagittal osteotomy. An 
anterior approach is required when the tumor is growing anteriorly and a margin of normal 
tissue must be left under visual control over the tumor, or vital structures must be protected. 
One or more neuroforamina are involved by tumor and the corresponding nerve root(s) 
needs to be sacrificed in order to obtain an appropriate margin. The uninvolved posterior 
elements are removed piecemeal. A complete release of the dural sac from the tumor should 
be done. Before the osteotomy, the contralateral pedicle is removed so that the dura is not 
retracted into its hard surface. First, the vertical cut is performed followed by the superior 
and inferior horizontal cut. The tumor is finally removed in one piece.  
Posterior resection: The posterior resection requires both pedicles free of tumor in order to 
obtain an oncologically appropriate margin. The posterior arch is removed after both 
pedicles are transected. This technique is rarely used for RCC metastases because the great 
majority of spinal metastases are located anteriorly in vertebral body.  
Vertebrectomy: Usually the surgical procedure is performed in two steps (first with the 
patient in prone decubitus position followed by a lateral oblique position at 45°), a posterior 
and anterior approach. For small lesions, inside the vertebral body the procedure can be 
done only by a posterior access with oncologically adequate margins, according to the 
technique described by Tomita et al. Although it is possible to perform an en bloc 
vertebrectomy using only the posterior approach in the lumbar spine, it should be avoided. 
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This technique involves a great risk of root damage and unlike the thoracic spine where one 
or more nerve roots can be sacrificed without causing major problems; in the lumbar spine a 
motor deficit can deteriorate dramatically the quality of life of these patients.  
The advantages of the posterior only approach are less surgical time and blood loss, 
avoidance of the anterior approach and its morbidity, among others. The most important 
disadvantage is the high risk of spinal cord lesion and the difficult to obtain adequate 
cutting surfaces on the spinal column in order to reconstruct the anterior column. 
Nowadays several devices and techniques have been developed to overcome these 
problems. The use of a spinal cord protector is important in these cases, and should always 
be applied. In all en bloc vertebrectomies performed using only a posterior approach, the 
authors used a special device named PROMID®, to protect the spinal cord and guide the 
saw path through the vertebral body or intervertebral disc. (Figure 4) The device is 
positioned underneath the dural sac and secured to a rod. Once the Gigli saw passes 
through the spinal column, the protector restrains it. The little knots on both sides work as 
the saw guide, avoiding the use of chisels and scalpels that can cause a massive bone 
bleeding and also injure the spinal cord.  
  
Fig. 4. The spinal cord protector and saw guide device (PROMID®) used during a posterior 
en bloc vertebrectomy. 
The choice of the best surgical treatment is still a matter of debate, however vertebrectomy is 
becoming more popular among spine surgeons. This technique requires a more experienced 
surgical team and an adequate clinical support. It is very important to keep in mind that 
RCC metastases are hypervascular tumors, and intralesional excision can be associated to 
massive blood loss. On the other hand, en bloc resection is associated to specific techniques, 
sometimes a combined anterior and posterior approach, and therefore a longer surgical 
time. It usually requires a prolonged anesthesia, hemodynamic stability, important blood 
loss compensation and control of body heat loss. To overcome the necessity to complement 
the surgical procedure with an anterior approach and therefore to deal with its 
complications, the use of anterior release using thoracoscopy can be done in some selected 
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cases with less morbidity without affecting the oncological management (Cappuccio et al., 
2010). 
Cappuccio et al., reported a retrospective study comparing the variation of intra-operative 
hemodynamic parameters (arterial blood pressure, cardiac frequency and hemoglobin 
levels) between a group of patients submitted to en bloc resection and a group treated by 
intralesional excision. Surgical timing was significantly higher in the en bloc resection 
group, however the cardiac frequency, hemoglobin levels and arterial blood pressure were 
significantly more affected in the patients submitted to intralesional excision. They 
concluded that constant evolution of the anesthesia techniques allows the execution of 
surgical treatments that have been forbidden in the past. Hemorrhagic tumors as RCC 
metastases can be better managed with en bloc resection, even considering that this is a 
more complex procedure compared to intralesional resection.  
Many authors reported the comparison between the different modalities of treatments for 
RCC spinal metastases. En bloc spondylectomy associated to adjuvant interferon and 
fractionated radiation presented good results with no recurrence in cases of solitary RCC 
metastases with epidural extension (Sakaura et al. 2004). In an unpublished series from 
Boriani, 90 cases of RCC were treated with a variety of techniques, including conventional 
external beam radiotherapy (4 patients), palliative decompression and instrumentation (19 
patients), intralesional gross total resection (42 patients), and en bloc resection (25 patients) 
with recurrence rates of 100%, 84%, 24%, and 4%, respectively. In the en bloc cohort, 12 
patients had no evidence of disease at a median follow-up of 30 months, 5 alive with disease 
at a median of 28 months, and 8 dead of disease at a median of 8 months. In the en bloc 
group, 1 patient showed local progression of disease (Bilsky et al., 2009). 
4.4 Spinal column reconstruction 
The surgical treatment of bone tumors usually results in a bone defect, secondary to 
curettage or resection that can be reconstructed using different types of implants associated 
to different methods of osteosynthesis. The complexity of the spinal anatomy requires a 
more specific and complex technique for resection and reconstruction. 
The spinal instability and the criteria for reconstruction of each patient is different case by 
case, and each type of resection (posterior, corpectomy or vertebrectomy) requires a specific 
reconstruction technique.  
Denis et al., have shown that the stability of the spine is secondary to the integrity of the 
middle column (posterior longitudinal ligament, posterior portion of the fibrous annulus e 
the posterior vertebral wall) e the anterior column (anterior longitudinal ligament, anterior 
portion of the fibrous annulus and the anterior vertebral wall). According to Gurwitz, and 
Lim et al., in cases where there is a lesion of the anterior column, a posterior stabilization is 
not sufficiently rigid to resist all weight bearing forces and therefore, needs to be associated 
to an anterior stabilization. In cases of en bloc vertebrectomy, a circumferential 
reconstruction is indispensable, in other words, it is necessary to associate a posterior 
stabilization to the anterior hardware. 
The posterior elements resection requires stabilization associated to a lateral arthodesis 
while corpectomy needs also the substitution of the vertebral body, associated to an anterior 
stabilization. 
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4.4.1 Posterior reconstruction 
In the majority of the cases an oncological surgical procedure in the spine produces a wide 
loss of substance associated to a major instability of the spine, thus becoming necessary a 
rigid stabilization of it. The most indicated system is the utilization of pedicle screws and 
longitudinal bars above and below the defect. In association for the patients that will not be 
submitted to radiotherapy, autogenous bone graft should also be used to obtain a 
permanent postero-lateral arthrodesis. 
4.4.2 Anterior reconstruction 
The anterior column is responsible for 80% of body weight support in the spine and its 
reconstruction is mandatory after en bloc vertebrectomies. The maintenance of the 
biomechanical principles is paramount. 
The size of the defect can be measure, and appropriately sized cage can be inserted. The 
reconstruction can be made using different cages (titanium, carbon fiber, etc.) or a massive 
allograft bone (femoral shaft). The cages or the bone shafts are filled preferably with 
autogenous bone. When possible, a connection between the anterior device and the 
posterior construct should be performed in order to enhance stability of the whole 
construct. 
The number of options for anterior column reconstruction devices is smaller than the 
posterior reconstruction. They are basically bars, plates and screws or cages that are 
anchored to the vertebral body. In spinal oncology these implants are frequently used to 
achieve an anterior stabilization especially at the long term, and also to provide an early 
rehabilitation.  
Orthopedic cement: The use of cement as a spacer, easily adaptable and with a low cost has 
been abandoned in the past. It has been proven not to be a reliable system at medium and 
long term (Boriani et al., 1996), being indicated only in selected cases of patients with short 
life expectancy. 
Bone Graft: Bone graft represents the oldest spacer used in the oncological surgery. The bone 
graft can be used to obtain an interbody fusion or to replace one or more vertebral bodies. 
The advantage of this kind of graft is its biological integrability. The disadvantages include 
the necessity of a bank bone (to collect, store, and distribute), risk of infection, the necessity 
of a long time to consolidate and therefore it needs to be protected (body casts, bed rest, 
etc.). All bone grafts are somehow damaged in the biological evolution in cases of post-
operative radiotherapy (Boriani et al., 1996).  
Vertebral prosthesis: There are many options of vertebral body replacement prosthesis. 
Nowadays the most common used are made of titanium, and recently, made of carbon 
fibers (Figure 5). The advantages are the immediate stability, they are not damaged by 
radiotherapy and there is no donor site morbidity. The disadvantages include the higher 
cost, the necessity to have different sizes available, to be responsible for images artifacts 
(image distortion in the MRI or CT-s can) and to interfere as an obstacle for post-operative 
radiotherapy if necessary.  
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Fig. 5. A Solitary RCC metastasis of L5; 5B. 64 months of follow-up after posterior 
stabilization and anterior reconstruction with a carbon fiber cage filled with allograft. The 
bone fusion of the anterior column can be seen thorough the cage. 
4.5 Stereotactic radiosurgery 
Renal cell carcinoma metastases are well known to be resistant to conventional 
radiotherapy. In recent years, stereotactic body radiosurgery (SBRS) have allowed the safe 
delivery of high-dose radiation (image-guided intensity-modulated radiation therapy or 
spinal radio- surgery) to spinal metastases even in close proximity to the spinal cord and 
other paraspinal dose-sensitive organs. These treatments are often given in 1 to 5 fractions of 
high-dose radiation (to ensure safe doses) that are able to limit the dose to the spinal cord 
(Gerzsten et al., 2009). The aims of SBRS for spinal metastases are to improve on existing 
rates of clinical response and tumor control, and to reduce the retreatment rate by increasing 
the biologic equivalent dose (Sahgal et al., 2009).  
According to Sahgal et al., the outcomes of spine radiosurgery can be grouped into four 
categories: 
1. Unirradiated patients: spinal metastases in a previously unirradiated volume treated 
with SBRS. 
2. Reirradiated patients: spinal metastases in a previously irradiated volume now 
containing new, recurrent, or progressive metastatic disease treated with SBRS. 
3. Postoperative SBRS patients: spinal metastases treated with SBRS after open surgical 
intervention, with or without spinal stabilization. 
4. Mixed patients: mixed populations involving patients in the previous 3 categories in 
which outcomes are not separately reported. 
Gerzsten et al., reported a durable pain improvement in 94% of patients with RCC 
metastasis in the spine treated with radiosurgery. In his systematic review of the literature, 
radiographic control has been reported to be up to 87% in RCC (Gerzsten et al., 2009). 
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The use of stereotactic radiosurgery as primary option of treatment is indicated in cases of 
patients undergoing treatment to a symptomatic spine lesion with other significant but 
asymptomatic spine metastases. These asymptomatic metastases may be treated with 
radiosurgery to avoid further irradiation to the neural elements as well as to avoid further 
bone-marrow suppression and permit subsequent systemic therapy. The benefits for this 
approach include a single treatment that is radiobiologically larger than can be delivered 
with standard radiotherapy, with a minimal radiation dose to adjacent normal tissue. When 
used as a primary treatment modality, long- term radiographic tumor control was 
demonstrated in 90% of cases of isolated RCC metastases. 
Stereotactic radiosurgery may be also indicated to treat patients presenting progressive 
neurologic deficit, where open surgery is contra-indicated, or in cases where the tumor is 
partially resected (intralesional resection) radiosurgery can be used to treat a residual tumor 
at a later date. In cases of severe compression of neural elements, the radiosurgery is not 
indicated and open procedure should be performed. Radiosurgery can also be used after 
vertebral body cement augmentation, with a local control rate as high as 92% (Gibbs et al., 
2009). 
Appropriate dose and fractionation schedules have not been determined and differ among 
institutions. There are institutions where the protocols include single-fraction radiosurgery 
from eight to 24 Gy or hypofractionated regimens consisting in different doses and number 
of fractions. 
Complications associated to radiosurgery include esophagitis, mucositis, dysphagia, 
diarrhea, paresthesia, transient laryngitis, and transient radiculitis. Spinal cord injury has 
been reported, but is considered exceedingly rare. 
Although the results so far reported using stereotactic radiosurgery have shown to be 
satisfying and promising, this technique does not treat spinal instability caused by the 
majority of the spinal tumors, and is contra-indicated in severe neural compression. 
Analysis of local tumor control rates after en bloc resection of solitary vertebral RCC 
metastases and after stereotactic radiosurgery appears to have comparable tumor control 
rates. The mean follow-up in Gerszten series of 60 patients treated with radiosurgery was 37 
months and his final outcomes were comparable to the patients followed by Boriani, which 
showed 48% of patients with no evidence of disease after 30 months, while 52% presented 
systemic progression and were dead at eight to 28 months. Long-term prospective 
randomized studies are still to be done in order to establish to best indications and protocols 
for the use of stereotactic radiosurgery in RCC metastasis. 
Recently, the Spine Oncology Study Group (SOSG) has conducted a systematic review 
trying to answer the following question “What is the optimal treatment for solitary renal cell 
metastases without significant epidural disease?”. Their conclusion was that there is a very 
low quality of evidence, however stereotactic radiosurgery should be the first line therapy 
rather than en bloc resection (Bilsky et al., 2009). 
4.6 Other treatment modalities 
Radiotherapy is well known to be less effective in RCC metastases. Its use in higher doses to 
reach a satisfactory response increases the risk of spinal cord lesions, and also the side 
effects associated to it. The relationship between radiotherapy dose and duration of 
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response has not been well studied, and the results are conflicting in the literature. The 
palliation of bone pain has been reported to be satisfying by Wilson et.al when compared 
with the palliation of symptoms at other sites of metastases, but the duration of this effect is 
still controversial. Higher biological effective dose does not seem to be a predictor of 
response or of duration of response in the palliative treatment of RCC. 
The development of new management techniques of vertebral metastatic lesions has 
increased. Vertebroplasty, kyphoplasty, and thermablation using radiofrequency techniques 
have been used. Radiofrequency is fairly used throughout the world, but results evaluating 
the tumor necrosis have been reported by Gasbarrini et al. in 2009. The purpose of this 
technique is to selectively destroy the metastatic lesion with local hyperthermia as well as 
resulting in thrombosis of the local paravertebral veins. In their report, the authors analyzed 
the tumor necrosis rate under light microscope and also under electronic microscope. They 
found that good results can be achieved in solid tumors as liver tumors, however the 
necrosis rate in RCC metastases were different, showing less necrosis rates. Their possible 
hypothesis for the treatment failure is that in highly vascular tumors is probably difficult to 
maintain the necessary temperature in situ for adequate necrosis. Selective arterial 
embolization should be considered prior to radiofrequency ablation in RCC metastases. 
The use of vertebroplasty, and/or kyphoplasty in spinal metastases has no effect as far as 
inducing tumor necrosis. Considering the heat generated by the cement and its duration as 
heat source, these techniques should not be used for that purpose. The use of cement inside 
the vertebral body is indicated in spinal oncology to increase the vertebrae’s resistance and 
to treat spinal instability secondary to pathologic fractures. 
It is very important to always keep in mind that these treatment modalities (vertebroplasty, 
kyphoplasty, and thermoablation are absolutely palliative and aims only to alleviate the pain. 
5. Conclusion 
The different therapeutic options and their indications in the treatment of patients with RCC 
metastatic disease can be distributed as follow: 
1. Only radiotherapy:  
- Multiple osseous metastases 
- Untreatable visceral metastases 
- Untreatable primary tumor 
- Patient’s poor clinical conditions 
2. Decompression, and stabilization associated to radiotherapy: 
- Intractable pain and/or neurological deficit in patients with disseminated disease 
- Untreatable or treatable visceral metastases 
3. Intralesional excision and radiotherapy: 
- Solitary bone metastasis (in cases where en bloc resection is contra-indicated)  
- Treatable visceral metastasis 
- En bloc resection not feasible 
4. En bloc resection: 
- Solitary bone metastasis 
- Treated primary tumor 
- Absence of visceral metastasis 
www.intechopen.com
 Management of Renal Cell Carcinoma Metastasis of the Spine 331 
- Technically feasible 
5. Stereotactic radiosurgery: 
- Solitary bone metastasis 
- Absence or with minimal epidural disease 
- Absence of severe spinal instability 
Considering all the treatment options, the management of RCC metastases is essentially a 
surgical treatment. The use of stereotactic radiosurgery has proven to be effective and 
comparable to en bloc resection for selected cases, however we need to consider that this 
treatment requires a very specific technology that, so far, is not widely available for the 
majority of treatment centers and patients throughout the world. This technique also does 
not provide any kind of mechanical reinforcement to the spinal instability.  
The progressive increase of the life expectancy of these patients, associated to the low 
sensitivity to conventional radiotherapy and the absence of a valid protocol of 
chemotherapy, makes surgery, associated to immunotherapy, the treatment of election, 
especially in cases of targeted therapies fail. Furthermore, the vertebral location of the 
lesion, determines a severe compromise of the quality of life often caused by intractable pain 
and elevated risk of paralysis and/or pathological fracture. In this last case the surgical 
treatment is performed in an emergency basis and therefore associated to all the 
anesthesiology and surgical complication that an urgent procedure can have. 
The final results, comparing the en bloc resection to intralesional excision associated to 
radiotherapy, seems to be similar considering the local control and long term survival. The 
comparison between the two options as far as morbidity and cost/efficacy favors the en bloc 
resection. 
Isolated surgery is indicated in cases of isolated metastases, and when during the 
preoperative planning, the procedure is planned to be outside the tumor capsule 
(extralesional). Selected cases of small tumors in favorable locations, where en bloc 
spondilectomy is feasible, associated to good prognosis of the primary disease, en bloc 
resection should be the treatment of choice. This is particularly true in cases of RCC 
metastases, because of its high risk of local recurrence, after intralesional excision even if 
combined with radiotherapy. In reality, the worst result after curettage occurs in cases of 
incomplete excisions (posterior only approach) and the effect of additional radiotherapy is 
incapable to eradicate the lesion. This findings confirm that the intralesional excision needs 
to be complete (outside the tumor capsule) in tumors partially or totally radioresitant, like 
the renal cell carcinoma, becoming necessary a double surgical approach. 
Both palliative surgery and intralesional excision may allow, in a good amount of patients, a 
certain degree of neurological improvement in the short term (improving quality of life), 
however the survival percentage at mid term is shorter for the patients treated with simple 
decompression and stabilization of the spine. Although we need to consider that, in general, 
patients treated with palliative surgery are in worse condition compared to those treated 
with intralesional excision. In cases of intralesional surgery, the use of adjuvant radiation 
therapy is indicated even considering the low sensitivity of tumor to this treatment.  
Immunotherapy should always be associated to the post-operative radiotherapy, because it 
has been demonstrated that the association of the adjuvant therapy increases the survival, 
independently of the surgical technique applied.  
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The use of isolated radiation therapy is indicated only in the face of multiple RCC 
metastases in patients with a poor prognosis. Even in those cases, when radiation therapy 
fails to mitigate pain and/or in the presence of a pathologic fracture with progressive 
neurological deterioration, a surgical intervention with decompression and stabilization 
should be performed. 
The early diagnosis of the primary tumor, the presence and location of the metastatic 
disease are paramount. The possibility of detecting the metastatic lesion in an early stage 
allows the spine surgeon to choose the best treatment for each patient and for each lesion. 
Unfortunately, the identification of these patients in an advanced stage makes the surgical 
intervention only a palliative measure used in cases of pathological fractures or severe 
neurological deficit. On the other hand, the early intervention permits a better local control 
of the disease, increasing the success possibility as far as improving the neurological status 
and treating the pain.  
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